Promising drug target in certain breast and ovarian cancers

13 febrero 2015

Scientists indicate that the pool of patients who can benefit from the drug olaparib is potentially much wider – and offers a ready means of identifying them.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Vi3qss9p10E/150213112112.htm